The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia
Hematological malignancies possess a distinctive immunologic microenvironment compared with solid tumors. Here, using an established computational algorithm (CIBERSORT), we systematically analyzed the overall distribution of 22 tumor-infiltrating leukocyte (TIL) populations in more than 2000 bone ma...
Main Authors: | Zi-Jun Xu, Yu Gu, Cui-Zhu Wang, Ye Jin, Xiang-Mei Wen, Ji-Chun Ma, Li-Juan Tang, Zhen-Wei Mao, Jun Qian, Jiang Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2019.1683347 |
Similar Items
-
CD86+/CD206+, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis
by: Pingping Dong, et al.
Published: (2016-03-01) -
CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma
by: Dalong Sun, et al.
Published: (2020-01-01) -
The Prognostic Value of CD206 in Solid Malignancies: A Systematic Review and Meta-Analysis
by: Jens M. Debacker, et al.
Published: (2021-07-01) -
High CD206 levels in Hodgkin lymphoma‐educated macrophages are linked to matrix‐remodeling and lymphoma dissemination
by: Annekatrin Arlt, et al.
Published: (2020-03-01) -
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
by: Marlene Christina Nielsen, et al.
Published: (2020-05-01)